Search

Author/Creator Lamas, J. L.

1. Pharmacokinetics, efficacy and safety of BAX326, a novel recombinant factor IX: a prospective, controlled, multicentre phase I/III study in previously treated patients with severe (FIX level <1%) or moderately severe (FIX level ≤2%) haemophilia B. (9th July 2013)

Authors:
Windyga, J.; Lissitchkov, T.; Stasyshyn, O.; Mamonov, V.; Rusen, L.; Lamas, J. L.; Oh, M.‐S.; Chapman, M.; Fritsch, S.; Pavlova, B. G.; Wong, W.‐Y.; Abbuehl, B. E.
Journal:
Haemophilia
Issue:
Volume 20:Number 1(2014:Jan.)
Page Start:
15
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search